Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00462631

Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients (PEPCAD IV)

Paclitaxel-Eluting Balloon Angioplasty and Cobalt-Chromium Stents Versus Conventional Angioplasty and Paclitaxel-Eluting Stents in the Treatment of Native Coronary Artery Stenoses of Diabetic Patients

Sponsor: B. Braun Medical SA

Conditions Coronary Stenosis Diabetes Mellitus

Interventions Paclitaxel Eluting Balloon bare metal stent paclitaxel eluting stent

Updated 5 times since 2017 Last updated: Feb 18, 2016 Started: May 31, 2007 Primary completion: Sep 30, 2011 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Coronary Stenosis and Diabetes Mellitus, this trial is completed. The trial is conducted by B. Braun Medical SA and has accumulated 5 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B. Braun Medical SA
Heart Centre Rotenburg

Data source: Heart Centre Rotenburg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuala Lumpur, Malaysia